Non-vitamin K antagonist oral anticoagulants versus warfarin for cardioversion of atrial fibrillation in clinical practice: A single-center experience

BACKGROUND: Anticoagulation therapy with the vitamin K antagonist (VKA) warfarin has been demonstrated to reduce thromboembolic risk after electrical cardioversion (ECV). However, data concerning ECV with non-VKA oral anticoagulants (NOACs) is limited. The objective of this study was to determine th...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Naoki, Morishima, Itsuro, Okumura, Kenji, Morita, Yasuhiro, Takagi, Kensuke, Yoshida, Ruka, Nagai, Hiroaki, Tomomatsu, Toshiro, Ikai, Yoshihiro, Terada, Kazushi, Tsuzuki, Kazuhito, Tsuboi, Hideyuki, Sone, Takahito, Murohara, Toyoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300843/
https://www.ncbi.nlm.nih.gov/pubmed/28217222
http://dx.doi.org/10.1016/j.joa.2016.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300843/
https://www.ncbi.nlm.nih.gov/pubmed/28217222
http://dx.doi.org/10.1016/j.joa.2016.04.003

Ejemplares similares